Skip to content
healthcare.dev

Glycopyrrolate

NDC 62135-735, Glycopyrrolate, tablet, from Chartwell RX, LLC.

Product NDC
62135-735
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207201
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-735 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCOPYRROLATE2 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
62135-735-606213507356060 TABLET in 1 BOTTLE (62135-735-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5773cf63-4006-4d8f-b53b-c84bcfe19e4a
  • NADAC price for package 62135073560

    GET /v1/drugs/nadac/62135073560

Use it

Look up 62135-735 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-735 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-735. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.